Adline Chem Lab Board of Directors
Get the latest insights into the leadership at Adline Chem Lab. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Sarang Bharatbhai Pathak | Managing Director |
| Mr. Hemant Amrish Parikh | Director |
| Mr. Dhawal Akhilesh Deopura | Director |
| Ms. Shivani Pathak | Director |
| Mr. Vrushank Balkrushna Patel | Additional Director |
| Mr. Nilay Jitendrabhai Vaghasiya | Additional Director |
Adline Chem Lab Share price
ADLINE
00.0
0 (0.00%)Last updated on 15 Sep, 2025 | 16:00 IST
BUYSELL
Today's High
00
Today's Low
00
52 Week Low
0.00
52 Week High
0.00
The current prices are delayed, login to your account for live prices
LoginAdline Chem Lab FAQs
The board at Adline Chem Lab consists of experienced professionals, including Mr. Sarang Bharatbhai Pathak , Mr. Hemant Amrish Parikh , and others, overseeing the company’s strategic and corporate governance.
Directors at Adline Chem Lab are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Sarang Bharatbhai Pathak is the current chairman at Adline Chem Lab.
Executive directors at Adline Chem Lab are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Adline Chem Lab adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Adline Chem Lab, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.